| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/16/2008 | EP1261694B1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 01/16/2008 | EP1228193B1 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107358A Nucleic acids for apoptosis of cancer cells |
| 01/16/2008 | CN101104856A Series of non-viral vectors and pharmaceutical composition containing the same |
| 01/16/2008 | CN101104855A Chicken interleukins 18 gene eukaryon expression plasmid construction and immunity effect |
| 01/16/2008 | CN101104852A Human new gene LOC344967 correlated with nasopharyngeal carcinoma and coding protein product thereof |
| 01/16/2008 | CN101104632A Antisense oligonucleotide using apoptosis gene Caspase-4 as drone and use thereof |
| 01/16/2008 | CN100361710C Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319141 Stem cell growth factor-like polypeptides |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319034 Modifications of apoptin |
| 01/15/2008 | US7319033 Transcritpional control; prostate glands; anticancer agents |
| 01/15/2008 | US7319004 Materials and methods relating to polyions and substance delivery |
| 01/15/2008 | US7319002 Using 2-3,O-sialic acid immobilized solid support to detect adenoviral infection; pathogen diagnostics |
| 01/15/2008 | US7319001 Generating transgenic viral particle via enzymatic digestion, ligation and propagagtion in host |
| 01/15/2008 | US7318936 Minimization of drug oxidation in drug irradiated excipients formulations |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | US7318924 Antibodies against cancer |
| 01/15/2008 | US7318919 Adenovirus vectors for gene therapy |
| 01/15/2008 | CA2221496C Production scale method of forming microparticles |
| 01/15/2008 | CA2205874C Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 01/11/2008 | CA2552493A1 Methods for producing interfering rnas |
| 01/10/2008 | WO2008006019A2 Growth hormone releasing hormone treatment to decrease cholesterol levels |
| 01/10/2008 | WO2008006007A2 Defective cystic fibrosis transduction regulator (cftr) causes increased sphingolipid synthesis |
| 01/10/2008 | WO2008005929A2 Recombinant hiv-1 gp120 immunogen with three different v3 loops from viruses of different clades |
| 01/10/2008 | WO2008005769A2 Methods of inhibiting hcv replication |
| 01/10/2008 | WO2008005562A2 Rna silencing compositions and methods for the treatment of huntington's disease |
| 01/10/2008 | WO2008005528A2 Compositions and methods for the modulation of detrusor activity |
| 01/10/2008 | WO2008005021A1 Use of crystallin for the modulation of angiogenesis |
| 01/10/2008 | WO2008004972A2 Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions |
| 01/10/2008 | WO2008003329A2 Nanoparticles for nucleic acid delivery |
| 01/10/2008 | WO2007107380A3 Use of pol iii promoters for controlled expression of therapeutic proteins |
| 01/10/2008 | WO2007089611A3 Compositions and their uses directed to huntingtin |
| 01/10/2008 | WO2005084137A3 Cd25 dna vaccines for treating and preventing t-cell mediated diseases |
| 01/10/2008 | WO2005042002A3 Treatment of rhematoid arthritis with flip antagonists |
| 01/10/2008 | US20080010694 Method of acquiring immunological tolerance |
| 01/10/2008 | US20080009458 medical diagnosis of cancer comprising detecting constitutive photomorphogenic 1(COP1) molecule in a sample of the cancer, wherein gene overexpression of the (COP1) molecule relative to a control is indicative of cancer |
| 01/10/2008 | US20080009456 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation |
| 01/10/2008 | US20080009455 Immunostimulatory oligonucleotides |
| 01/10/2008 | US20080009447 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal |
| 01/10/2008 | US20080009438 Screening methods for compounds useful in the regulation of body weight |
| 01/10/2008 | US20080009060 Methods of discovering chemicals capable of functioning as gene expression modulators |
| 01/10/2008 | US20080009030 inhibition of PUMA function (p53 upregulated modulator of apoptosis; also referred to as Bbc-3: Bcl-2 binding component-3) |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080009022 Immunization of dairy cattle with chimeric gapC protein against streptococcus infection |
| 01/10/2008 | US20080009008 Composition and method for treating lupus nephritis |
| 01/10/2008 | US20080008717 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus |
| 01/10/2008 | US20080008691 Modified growth hormone |
| 01/10/2008 | US20080008690 AAV virions with decreased immunoreactivity and uses therefor |
| 01/10/2008 | US20080008689 Method for Transdifferentiation of Non Pancreatic Stem Cells to the Pancreatic Differentiation Pathway |
| 01/10/2008 | US20080008688 System and Method for Genetically Treating Cardiac Conduction Disturbances |
| 01/10/2008 | US20080008687 Transposon-Based Targeting System |
| 01/10/2008 | US20080008686 Tetracycline repressor regulated oncolytic viruses |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | US20080008684 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 01/10/2008 | DE19933492B4 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung A conjugate for placement of a cell, or membrane compartment-specific transport of active substances, a process for its preparation and its use |
| 01/10/2008 | DE10109466B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 01/10/2008 | CA2706124A1 Nanoparticles for nucleic acid delivery |
| 01/10/2008 | CA2667974A1 Chimeric zinc finger recombinases optimized for catalysis by directed evolution |
| 01/10/2008 | CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/09/2008 | EP1876241A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1875927A1 Methods for evaluating a compound for its effect on skin |
| 01/09/2008 | EP1875247A2 Selective modulation of tumour necrosis factor receptors in therapy |
| 01/09/2008 | EP1874930A2 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer |
| 01/09/2008 | EP1874844A1 Hyperbranched polymers and their applications |
| 01/09/2008 | EP1874824A2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 01/09/2008 | EP1874358A2 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 01/09/2008 | EP1750774A4 Composition and method of cancer treatment |
| 01/09/2008 | EP1572917A4 Antibody gene transfer and recombinant aav therefor |
| 01/09/2008 | EP1527086B1 Compounds binding to p-selectin |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1129196B1 Virulence genes and proteins, and their use |
| 01/09/2008 | EP1040189B1 Polypeptides, their production and use |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | EP0917581B1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 01/09/2008 | CN101103112A Compositions and methods for short interfering nucleic acid inhibition of Nav1.8 |
| 01/09/2008 | CN101103111A Compositions for treating respiratory viral infections and their use |
| 01/09/2008 | CN101102798A Compositions and methods for regulated protein expression in gut |
| 01/09/2008 | CN101102795A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 01/09/2008 | CN101102788A Fibrosis inhibitor for implanted organ |
| 01/09/2008 | CN101102733A Macromolecule-containing sustained release intraocular implants and related methods |
| 01/09/2008 | CN101100679A Construction of adenovirus for expressing suppressor cell growth polypeptide and application thereof |
| 01/09/2008 | CN101100672A Modified HPV E6-E7 fusion gene and coding protein thereof |
| 01/09/2008 | CN101100671A Human anti-HBsAg single-chain antibody/human antibody light chain constant region/protamine truncated recombination gene, coding protein and application |
| 01/09/2008 | CN101100666A Human TCRVbeta7.1_H3F7 gene and its screening method and application |
| 01/09/2008 | CN101100487A Fusion protein capable of removing HPV E7 protein and its encoding gene and application |
| 01/09/2008 | CN101099869A Method for using siRNA composition to treat disease and improve siRNA effect in RNAi |
| 01/09/2008 | CN100360665C I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application |
| 01/09/2008 | CN100360565C Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 01/09/2008 | CN100360560C Use of DLP in Pre-mRNA splicing and cell cycle control |
| 01/09/2008 | CN100360556C Hepatitis B core antigen fusion proteins |
| 01/08/2008 | US7317097 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 01/08/2008 | US7317096 Isolated or recombinant nucleic acid sequence encoding an (AAP-1), |